Covered recipient · General Payments record
BRIAN E TSCHIDA
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2022
$1,523.98
- Reported across 91 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2022 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $197.89 | 12 |
By paying entity
PY2022 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $57.82 | 3 |
| Amgen Inc. | $38.32 | 3 |
| Allergan Inc. | $34.23 | 2 |
| CSL Behring | $21.67 | 1 |
| JAZZ PHARMACEUTICALS INC. | $16.18 | 1 |
| Kyowa Kirin, Inc. | $16.11 | 1 |
| Avanir Pharmaceuticals, Inc. | $13.56 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2022 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $25.22 | 04/14/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892556209 | CMS |
| ABBVIE INC. | $16.54 | 06/21/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892556211 | CMS |
| ABBVIE INC. | $16.06 | 07/07/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892556213 | CMS |
| Allergan, Inc. | $16.42 | 03/01/2022 | Food and Beverage | Undisputed | 01/23/2026 | 889999259 | CMS |
| Allergan, Inc. | $17.81 | 03/30/2022 | Food and Beverage | Undisputed | 01/23/2026 | 889999261 | CMS |
| Amgen Inc. | $11.97 | 05/05/2022 | Food and Beverage | Undisputed | 01/23/2026 | 939290597 | CMS |
| Amgen Inc. | $12.95 | 06/29/2022 | Food and Beverage | Undisputed | 01/23/2026 | 939290595 | CMS |
| Amgen Inc. | $13.40 | 08/04/2022 | Food and Beverage | Undisputed | 01/23/2026 | 939290599 | CMS |
| Avanir Pharmaceuticals, Inc. | $13.56 | 02/01/2022 | Food and Beverage | Undisputed | 01/23/2026 | 935919699 | CMS |
| CSL Behring | $21.67 | 08/11/2022 | Food and Beverage | Undisputed | 01/23/2026 | 940875433 | CMS |
| JAZZ PHARMACEUTICALS INC. | $16.18 | 07/25/2022 | Food and Beverage | Undisputed | 01/23/2026 | 951383979 | CMS |
| Kyowa Kirin, Inc. | $16.11 | 06/22/2022 | Food and Beverage | Undisputed | 01/23/2026 | 905040249 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022
- Generated from
- OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.